Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Chinese Patent Office
US Department of Justice
McKinsey
QuintilesIMS
Baxter
Covington
Citi
Cantor Fitzgerald
Healthtrust

Generated: October 20, 2017

DrugPatentWatch Database Preview

Promius Pharma Llc Company Profile

« Back to Dashboard

What is the competitive landscape for PROMIUS PHARMA LLC, and when can generic versions of PROMIUS PHARMA LLC drugs launch?

PROMIUS PHARMA LLC has two approved drugs.

There are four US patents protecting PROMIUS PHARMA LLC drugs.

There are five patent family members on PROMIUS PHARMA LLC drugs in four countries.

Summary for Applicant: Promius Pharma Llc

International Patents:5
US Patents:4
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Promius Pharma Llc
CLODERM
clocortolone pivalate
CREAM;TOPICAL017765-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Promius Pharma Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,775,851Topical formulations comprising a steroid► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Promius Pharma Llc Drugs

Country Document Number Estimated Expiration
European Patent Office2473161► Subscribe
Japan5833007► Subscribe
European Patent Office3141246► Subscribe
World Intellectual Property Organization (WIPO)2011026076► Subscribe
Japan2013503203► Subscribe
Denmark2473161► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Baxter
US Army
Medtronic
Cantor Fitzgerald
Cerilliant
Julphar
Deloitte
Argus Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot